However, the role of PPARγ in tumorigenesis is controversial, stemming from the discrepancy between the anticancer effects suggested by in vitro studies, and the tumor-promoting capacity reported in mouse models of colon cancer [8]. The gene discussed is PPARG; the disease is neoplasm.